SLI
1.986,02
PKT
+13,07
PKT
+0,66
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.05 | Givaudan Neutral | Sarasin Research | |
| 21.01.05 | Nestlé Kaufen | Helaba Trust | |
| 18.01.05 | Novartis Buy | AG Edwards | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Novartis Outperform | Bear Stearns | |
| 18.01.05 | Nestlé Buy | Helvea | |
| 18.01.05 | Lonza Buy | Helvea | |
| 18.01.05 | Novartis Buy | Sarasin Research | |
| 24.01.05 | Swiss Life Neutral | Sal. Oppenheim | |
| 18.01.05 | Richemont Overweight | Lehman Brothers | |
| 18.01.05 | Roche Buy | Merrill Lynch | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 20.01.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 18.01.05 | Novartis Akkumulieren | Independent Research | |
| 24.01.05 | Zurich Insurance Neutral | Sal. Oppenheim | |
| 18.01.05 | Geberit Market Outperform | Vontobel | |
| 17.01.05 | Logitech Buy | Sarasin Research | |
| 17.01.05 | Holcim Halten | Helaba Trust | |
| 17.01.05 | Novartis Sector Outperform | Vontobel | |
| 17.01.05 | Temenos Overweight | Lehman Brothers | |
| 18.01.05 | UBS Buy | Sarasin Research | |
| 17.01.05 | Swiss Life Outperform | HypoVereinsbank | |
| 17.01.05 | Lonza Reduce | Sarasin Research | |
| 17.01.05 | Richemont Buy | Sarasin Research | |
| 17.01.05 | Swiss Life Buy | M.M. Warburg | |
| 20.01.05 | Swiss Life Halten | Bankhaus Lampe | |
| 14.01.05 | Geberit Buy | Sarasin Research | |
| 14.01.05 | Novartis Kaufen | Helaba Trust | |
| 18.01.05 | UBS Empfehlungsliste | Erste Bank | |
| 14.01.05 | Novartis Overweight | Lehman Brothers | |
| 18.01.05 | Novartis Empfehlungsliste | Erste Bank | |
| 13.01.05 | Holcim In-Line | Goldman Sachs | |
| 14.01.05 | UBS Kaufen | Hamburger Sparkasse | |
| 18.01.05 | Straumann Outperform | Credit Suisse First Boston | |
| 13.01.05 | Logitech Market Perform | Vontobel | |
| 14.01.05 | ABB (Asea Brown Boveri) Halten | Hamburger Sparkasse | |
| 17.01.05 | Sonova Outperform | Credit Suisse First Boston | |
| 13.01.05 | Novartis Buy | AG Edwards | |
| 12.01.05 | Novartis Hold | Smith Barney Citigroup | |
| 13.01.05 | Holcim Halten | Helaba Trust |